gdc-0973 and Anemia

gdc-0973 has been researched along with Anemia* in 1 studies

Other Studies

1 other study(ies) available for gdc-0973 and Anemia

Article	Year
Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma. Acta dermato-venereologica, 2022, Feb-22, Volume: 102 Topics: Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Humans; Melanoma; Piperidines; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Vemurafenib	2022

Article

Year

Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma.

Acta dermato-venereologica, 2022, Feb-22, Volume: 102

Topics: Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Humans; Melanoma; Piperidines; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Vemurafenib

2022